AI is so energy-hungry that most data analysis must be performed in the cloud New energy-efficient device enables AI tasks to be performed within wearables This allows real-time analysis and diagnostics for faster medical interventions Researchers tested the device by classifying 10,000 ele.
Get a Wonderful Person Tee: https://teespring.com/stores/whatdamath.
More cool designs are on Amazon: https://amzn.to/3wDGy2i.
Alternatively, PayPal donations can be sent here: http://paypal.me/whatdamath.
Hello and welcome! My name is Anton and in this video, we will talk about an invention of a DNA bio computer.
Links:
https://www.nature.com/articles/s41586-023-06484-9
https://www.washington.edu/news/2016/04/07/uw-team-stores-di…perfectly/
Other videos:
https://youtu.be/x3jiY8rZAZs.
https://youtu.be/JGWbVENukKc.
#dna #biocomputer #genetics.
0:00 Quantum computer hype.
0:50 Biocomputers?
1:55 Original DNA computers from decades ago.
3:10 Problems with this idea.
3:50 New advances.
5:35 First breakthrough — DNA circuit.
7:30 Huge potential…maybe.
Support this channel on Patreon to help me make this a full time job:
While it is well known that certain brain regions play a crucial role in memory processes, so far it has not been clear whether these regions exhibit different activities when it comes to storing information in people with better or worse memory performance.
Having investigated this matter, a research team led by Professor Dominique de Quervain and Professor Andreas Papassotiropoulos has now published its results in the journal Nature Communications.
In the world’s largest functional imaging study on memory, they asked nearly 1,500 participants between the ages of 18 and 35 to look at and memorize a total of 72 images. During this process, the researchers recorded the subjects’ brain activity using MRI. The participants were then asked to recall as many of the images as possible – and as in the general population, there were considerable differences in memory performance among them.
Relief could be on the way for people with painful hand osteoarthritis after a Monash University and Alfred Health-led study found an affordable existing drug can help. Until now there has been no effective treatment.
Published in The Lancet, the paper investigated methotrexate, a low-cost, effective treatment for inflammatory joint conditions such as rheumatoid arthritis and psoriatic arthritis. It has been widely used in Australia and globally since the early 1980s.
Researchers found that methotrexate reduced symptoms in those with hand osteoarthritis (OA). A 20mg weekly oral dose over six months had a moderate effect in reducing pain and stiffness in patients with symptomatic hand OA.
🥼 Researchers from the Netherlands Institute for Neuroscience and the VIB-KU Leuven Center for Brain and Disease Research have shown that microRNA-132 can significantly affect different brain cells, with potential implications for Alzheimer’s disease ✔️
🔗
Research shows that microRNA-132 can significantly affect different brain cells, with potential implications for Alzheimer’s disease. Find out more.
The research paper explores the multifaceted role of the IL-17 family in immune response, covering everything from infection control to pathological conditions like autoimmune diseases and cancer. Future therapies may exploit IL-17’s unique signaling pathways to offer more targeted and cost-effective treatments.
A team of atmospheric scientists, chemists and infectious disease specialists at the Max Planck Institute for Chemistry, working with colleagues from the Max Planck Institute for Dynamical Systems, the University of Denver, Georg August University and St. Petersburg State University, has embarked on an effort to collate publicly available information on droplet properties, such as the way they are distributed by size, their composition, and the ways they are emitted, as a means of helping to develop mitigation strategies for fighting infectious agents.
In their paper published in the journal Reviews of Modern Physics, the group describes their collating process and why they believe it could help fight non-contact infectious diseases.
In the early days of the pandemic, as people around the world locked themselves inside their residences, scientists, including those not in the medical field, looked for ways to help. One such pair of researchers, Christopher Pöhlker, an atmospheric scientist, and his wife, Mira, a cloud scientist, began to wonder about the nature of droplet size—something related to both their fields of work.
Posted in biotech/medical, evolution
Do you think human beings are the last stage in evolution? If not, what comes next?
I do not think human beings are the last stage in the evolutionary process. Whatever comes next will be neither simply organic nor simply machinic but will be the result of the increasingly symbiotic relationship between human beings and technology.
Bound together as parasite/host, neither people nor technologies can exist apart from the other because they are constitutive prostheses of each other. Such an interrelation is not unique to human beings. As the physiologist J. Scott Turner writes in “The Extended Organism”: “Animal-built structures are properly considered organs of physiology, in principle no different from, and just as much a part of the organism as kidneys, heart, lungs or livers.” This is true for termites, for example, who form a single organism in symbiosis with their nests. The extended body of the organism is created by the extended mind of the colony.
Posted in biotech/medical
Researchers investigated how cancer antigenicity drives unique forms of T cell exhaustion and hypofunctionality.
An Australian first biobank will be established to improve and discover new treatments for children with genetic muscle diseases.
The National Muscle Disease Bio-databank, co-led by Murdoch Children’s Research Institute, Monash University and The Alfred, will advance research into our understanding of why children develop genetic muscle diseases.
These diseases, spanning dystrophies and myopathies, are characterised by severe muscle weakness, usually from infancy, that can impact swallowing, breathing and lead to eye problems and learning difficulties.
Housed at Murdoch Children’s, the biobank will store blood test and skin biopsy samples from children across Australia with genetic muscle disease.
Murdoch Children’s Dr Peter Houweling said the project aimed to develop new and better treatments and fast-track discoveries into clinical trials.
